Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_3613AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (25 micromolar)NoShanghai cell collectionHuman colorectal cancer cell lineHT-295000 cells per wellNAMTT assay10 MOI50% cell viability after 96 hoursNoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_3614AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (25 micromolar)NoShanghai cell collectionHuman colorectal cancer cell lineHT-295000 cells per wellNAMTT assay15 MOI60% cell viability after 24 hoursNoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_3615AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (25 micromolar)NoShanghai cell collectionHuman colorectal cancer cell lineHT-295000 cells per wellNAMTT assay15 MOI40% cell viability after 48 hoursNoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_3616AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (25 micromolar)NoShanghai cell collectionHuman colorectal cancer cell lineHT-295000 cells per wellNAMTT assay15 MOI40% cell viability after 72 hoursNoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_3617AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (25 micromolar)NoShanghai cell collectionHuman colorectal cancer cell lineHT-295000 cells per wellNAMTT assay15 MOI22% cell viability after 96 hoursNoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_3618AdenovirusAdenovirus CD55-TRAILDNAAdenoviridaeVirus expressingTRAIL geneNoVirus in combination with luteolin (50mg/kg)NoShanghai cell collectionHuman colorectal cancer cell lineHT-29NANANANANABalb/c nude mice xenograft for HT29 cell line (8.0E+6)2.0E+9 pfuNA Decrease in tumor volume to below 2000mm after 30 days comapred to control 4000mmIntratumoralVirus in combination with induce apiptosis in cancer cellNANA29039580
OV_4081AdenovirusAdenovirus ZD55DNAAdenoviridaeVirus encoded with drosophila dNK geneNoVirus in combination with drug BVDU(10mg/kg)NoShanghai cell collectionHuman breast cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOISignificant reduction in cell growthNoNoNA No responseNAVirus induced apoptosis in cancer cellNANA26203222
OV_4082AdenovirusAdenovirus ZD55DNAAdenoviridaeVirus encoded with drosophila dNK geneNoVirus in combination with drug DFDC(10mg/kg)NoShanghai cell collectionHuman breast cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOISignificant reduction in cell growthNoNoNA No responseNAVirus induced apoptosis in cancer cellNANA26203222
OV_4083AdenovirusAdenovirus ZD55DNAAdenoviridaeVirus encoded with drosophila dNK geneNoVirus in combination with drug DFDC(10mg/kg)NoShanghai cell collectionNANANANANANANABALB/c nude mice xenograft for MCF7 (1.0E+7)1.0E+9 pfuNA Virus and drug prolongs the mice survival and reduction in tumor volume to 1000mm compared to control 3000mm after 60 daysIntratumoralVirus induced apoptosis in cancer cellNANA26203222
OV_4110AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman colon carcinoma cell lineCaco-21.0E+5 cells per wellNAMTT assay0.1 MOI80% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4111AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman lung cancer cell lineA5491.0E+5 cells per wellNAMTT assay0.1 MOI90% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4112AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman osteosarcoma cell lineU2OS1.0E+5 cells per wellNAMTT assay0.1 MOI95% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4113AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman fibroblast cell line BJBJ1.0E+5 cells per wellNAMTT assay0.1 MOI95% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4114AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman colon carcinoma cell lineCaco-21.0E+5 cells per wellNAMTT assay1 MOI40% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4115AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman lung cancer cell lineCaco-21.0E+5 cells per wellNAMTT assay1 MOI50% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4116AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman osteosarcoma cell lineU2OS1.0E+5 cells per wellNAMTT assay1 MOI90% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4117AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman fibroblast cell lineBJ1.0E+5 cells per wellNAMTT assay1 MOI95% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4118AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman colon carcinoma cell lineCaco-21.0E+5 cells per wellNAMTT assay10 MOI10% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4119AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman lung cancer cell lineCaco-21.0E+5 cells per wellNAMTT assay10 MOI20% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4120AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman osteosarcoma cell lineU2OS1.0E+5 cells per wellNAMTT assay10 MOI90% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4121AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman fibroblast cell lineBJ1.0E+5 cells per wellNAMTT assay10 MOI90% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4122AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman colon carcinoma cell lineCaco-21.0E+5 cells per wellNAMTT assay100 MOI5% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4123AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman lung cancer cell lineCaco-21.0E+5 cells per wellNAMTT assay100 MOI30% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4124AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman osteosarcoma cell lineU2OS1.0E+5 cells per wellNAMTT assay100 MOI95% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4125AdenovirusAd-CCL20-CD40LDNAAdenoviridaeAddition of CCL20 and CD40L gene near by TERT promoterYesNovirus expressing CCL20 chemokine geneATCCHuman fibroblast cell lineBJ1.0E+5 cells per wellNAMTT assay100 MOI95% cell survival after 7 daysNoNoNA No responseNANANANA26208317
OV_4126AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (0.01 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100 vp/cell80% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4127AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000 vp/cell50% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4128AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay10000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4129AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4130AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4131AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4132AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000 vp/cell85% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4133AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay10000 vp/cell35% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4134AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4135AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4136AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4137AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4138AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100 vp/cell70% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4139AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4140AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4141AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100000000 ng/ml)NoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4142AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4143AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4144AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4145AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay1000 vp/cell40% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4146AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay10000 vp/cell10% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4147AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell linePANC-13.0E+3 cells per wellNAMTT assay100000 vp/cell100% cancer cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4148AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with gemcitabine (160mg/kg)NoNANANANANANANANAAthymic nude mice xenograft for BxPC-3 (5.0E+5)5.0E+10 VP per cellNA Median survival time increased from 22 days to 57 days with combined tretamentNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4149AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with gemcitabine (160mg/kg)NoNANANANANANANANAAthymic nude mice xenograft for PANC-1 (5.0E+5)5.0E+10 VP per cellNA Median survival time increased from 37 days to 79.5 days with combined tretamentNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4194Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 1NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4195Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 2NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4196Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 3NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4197Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 4NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4198Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 5NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4199AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 1NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4200AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 2NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4201AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 3NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4202AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI100% cell viability after day 4NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4203AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoCell bank of chinese academy of scienceHuman lung adenocarcinoma cell lineA5491.0E+6 cells per wellNACCK-8 assay100 MOI10% cell viability after day 5NoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4204AdenovirusAd-CXCR4-DAL1DNAAdenoviridaeVirus expressing DAL-1 gene under promoter CXXR4YesNoNoNANANANANANANANABALB/c nude mice subcutaneously xenograft for A549 cell (2.0E+6)1.0E+9 pfu, every other day for 3 timesNA Reduction in tumor volume to 1.5 centimeter cube after 28 days compared to control 7 centimeter cubeIntratumoralVirus induce apoptosis process leads to cancer cell deathNANA26280082
OV_4401AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method16.64+/- 1.4120% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4402AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method57.46+/- 8.3750% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4403AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAStatistical method96.31+/- 10.7670% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4404AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method16.56+/- 2.7820% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4405AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method52.17+/- 9.6850% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4406AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5a/carbo-15aNANAStatistical method90.13+/- 14.4270% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4407AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29NANAStatistical method26.80+/- 7.8220% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4408AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29NANAStatistical method74.23+/- 18.1950% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4409AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29NANAStatistical method127.2+/- 3970% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4410AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/CP-5cNANAStatistical method7.56+/- 1.9620% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4411AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/CP-5cNANAStatistical method26.70+/- 5.9050% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4412AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/CP-5cNANAStatistical method49.95+/- 9.0170% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4413AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/carbo-15d-1NANAStatistical method20.13+/- 10.2320% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4414AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/carbo-15d-1NANAStatistical method48.46+/- 19.0350% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4415AdenovirusONYX-015DNAAdenoviridaeNoneYesNoNoATCCHuman colon carcinomaHT-29/carbo-15d-1NANAStatistical method78.27+/- 25.1170% cancer cell deathNoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4416AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4417AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu6% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4418AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu10% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4419AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (2.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu3% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4420AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu15% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4421AdenovirusONYX-015DNAAdenoviridaeNoneNoVirus in combination with melphalan (7.5 microgram)NoSt. Joseph healthcare, LondonHuman head and neck squamous cell carcinomaHN-5aNANAFlow cytometry20 pfu25% cancer cell death after day 3NoNoNA No responseNAIncrease in apoptosis upto 25%NANA26429639
OV_4474AdenovirusoAD/DCN-shMetDNAAdenoviridaeAdenovirus conjugated with DCN and shMetYesNoNoATCCHuman lung carcinoma cell lineA54970% confluence in 24 well plateNAMTT assay1 MOI65% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 140pg/ml compared to control 20 pg/mlNA26951927
OV_4475AdenovirusoAD/DCN-shMet/PPDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and PEGylated at PAMAMYesNoNoATCCHuman lung carcinoma cell lineA54970% confluence in 24 well plateNAMTT assay1 MOI58% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4476AdenovirusoAD/DCN-shMet/PPEDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAMYesNoNoATCCHuman lung carcinoma cell lineA54970% confluence in 24 well plateNAMTT assay1 MOI18% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4477AdenovirusoAD/DCN-shMetDNAAdenoviridaeAdenovirus conjugated with DCN and shMetYesNoNoATCCHuman breast cancer cell lineMCF-770% confluence in 24 well plateNAMTT assay100 MOI88% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 140pg/ml compared to control 20 pg/mlNA26951927
OV_4478AdenovirusoAD/DCN-shMet/PPDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and PEGylated at PAMAMYesNoNoATCCHuman breast cancer cell lineMCF-770% confluence in 24 well plateNAMTT assay100 MOI85% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4479AdenovirusoAD/DCN-shMet/PPEDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAMYesNoNoATCCHuman breast cancer cell lineMCF-770% confluence in 24 well plateNAMTT assay100 MOI82% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4480AdenovirusoAD/DCN-shMetDNAAdenoviridaeAdenovirus conjugated with DCN and shMetYesNoNoATCCHuman breast cancer cell lineHDF70% confluence in 24 well plateNAMTT assay20 MOI90% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 140pg/ml compared to control 20 pg/mlNA26951927
OV_4481AdenovirusoAD/DCN-shMet/PPDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and PEGylated at PAMAMYesNoNoATCCHuman breast cancer cell lineHDF70% confluence in 24 well plateNAMTT assay20 MOI90% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4482AdenovirusoAD/DCN-shMet/PPEDNAAdenoviridaeAdenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAMYesNoNoATCCHuman breast cancer cell lineHDF70% confluence in 24 well plateNAMTT assay20 MOI90% cancer cell survivalability after 48 hoursNoNoNA No responseNANAIncreased in IL-6 level to 40pg/ml compared to control 20 pg/mlNA26951927
OV_4509AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell100% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4510AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4511AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell75% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4512AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay1 VP/cell62% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4513AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell90% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4514AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4515AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.0025mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4516AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.005mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay10 VP/cell70% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4517AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFYesNoNoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell40% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453
OV_4518AdenovirusAd5/3-D24-GMCSFDNAAdenoviridaeAd5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSFNoVirus in combination with 4-HP-CP (0.001mg/ml)NoATCCHuman breast cancer triple negative cell lineMDA-MB-4361000 cells per wellNAMTS assay100 VP/cell35% cancer cell survival after 5 daysNoNoNA No responseNANAVirus induced tumor specific T-cell responseNA27057453